ESR1 and breast cancer: The results from our spatial and single‐cell analyses were further validated by similarities to a human ER+ breast cancer single‐cell dataset21 and protein‐based dual IHC of SC31 showing the importance of clinical markers co‐localisation [i.e., ER, PR and Ki67].